Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in GILD — Gilead Sciences, Inc.

CIK 70858 CHARLOTTE, NC
Back to GILD Full portfolio

Position in GILD

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$2,784,464,307
-$53,483,328 QoQ
Shares Held
19,978,936
-13.6% QoQ
Ownership
1.61%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 19.563364135107093.ToString("F0")% Shared 0.ToString("F0")% None 80.4366358648929.ToString("F0")%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Sep 30, 2025
CallValue
$2,963,700
CallShares
26,700
PutValue
$10,056,600
PutShares
90,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

BANK OF AMERICA CORP /DE/ holds $38,990,456,692 across 16 Drug Manufacturers - General names. GILD ranks #6 (7.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 11,125,832 $10,233,206,495
2 JNJ
Johnson & Johnson
 25,516,697 $6,237,301,411
3 ABBV
AbbVie Inc.
 23,936,943 $5,206,045,728
4 AZN
Astrazeneca PLC
 19,058,327 $3,758,683,247
5 MRK
Merck & Co., Inc.
 30,774,221 $3,701,831,041
6 GILD
Gilead Sciences, Inc.
This page 		19,978,936 $2,784,464,307
7 BMY
Bristol Myers Squibb Co
 32,586,981 $1,976,400,394
8 AMGN
Amgen Inc
 5,121,028 $1,801,833,698

All Filings in GILD

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,784,464,307 19,978,936
2025-12-31 $2,837,947,635 23,121,620
2025-09-30 $2,235,410,352 20,138,832
2025-09-30 $10,056,600 90,600
2025-09-30 $2,963,700 26,700
2025-06-30 $16,575,065 149,500
2025-06-30 $2,104,568,040 18,982,304
2025-06-30 $6,596,765 59,500
2025-03-31 $19,295,010 172,200
2025-03-31 $33,783,075 301,500
2025-03-31 $2,056,435,380 18,352,837
2024-12-31 $1,636,582,099 17,717,680
2024-12-31 $28,828,677 312,100
2024-12-31 $20,016,579 216,700
2024-09-30 $27,365,376 326,400
2024-09-30 $12,928,128 154,200
2024-09-30 $606,163,783 7,230,007
2024-06-30 $10,744,326 156,600
2024-06-30 $457,987,527 6,675,230
2024-06-30 $30,359,925 442,500
2024-03-31 $484,656,864 6,616,476
2024-03-31 $39,767,425 542,900
2024-03-31 $19,733,550 269,400
2023-12-31 $26,895,320 332,000
2023-12-31 $523,523,637 6,462,457
2023-12-31 $21,435,246 264,600
2023-09-30 $402,997,641 5,377,604
2023-09-30 $20,301,246 270,900
2023-09-30 $18,757,482 250,300
2023-06-30 $414,585,113 5,379,332
2023-06-30 $41,001,240 532,000
2023-06-30 $16,677,948 216,400
2023-03-31 $638,807,847 7,699,263
2023-03-31 $24,077,894 290,200
2023-03-31 $37,709,865 454,500
2022-12-31 $44,281,430 515,800
2022-12-31 $56,248,920 655,200
2022-12-31 $651,065,191 7,583,753
2022-09-30 $39,247,178 636,200
2022-09-30 $430,713,283 6,981,898
2022-09-30 $31,554,435 511,500
2022-06-30 $455,239,546 7,365,144
2022-06-30 $26,195,078 423,800
2022-06-30 $17,479,868 282,800
2022-03-31 $461,940,645 7,770,238
2022-03-31 $25,343,535 426,300
2022-03-31 $79,597,605 1,338,900
2021-12-31 $508,850,004 7,007,988
2021-12-31 $83,240,104 1,146,400
2021-12-31 $116,989,232 1,611,200

Report a Problem

Category
Description
Email (optional, for follow-up)